Health
Moderna COVID-19 vaccine well-tolerated, generates immune response in older adults: Study – The Indian Express
The study, published in the New England Journal of Medicine, noted that the experimental vaccine, mRNA-1273, was well-tolerated by the older trial participants,…
By: AP | Boston |
Updated: September 30, 2020 7:40:28 pm
According to the researchers from NIAID, older adults are more vulnerable to complications of COVID-19, and are an important population for vaccination. (AP/File)Results from the Phase 1 trial of an investigational COVID-19 vaccine co-developed by researchers at the US National Institute of Allergy and Infectious Diseases (NIAID), and the American biotech company Moderna have shown that it is well-tolerated and generates a strong immune…
-
Noosa News22 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Business23 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Noosa News21 hours agoAfter Hours Gallery Visits, French Dining and Garden Illuminations: Your Guide to the Ultimate Melbourne Culture Fix
-
General18 hours agoDeath of 86-year-old driver in Karoonda Highway crash prompts push for change